Back

NVS Stock

Price Chart

📈
Loading chart for NVS...
Powered by TradingView

Detailed Market Analysis

Key Levels

Support
$146.33
Resistance
$161.73

Volume & Momentum

Volume
Weak
0.8x avg
Momentum
0%
Weak

Trading Setup

HOLD
Entry $154.03
Stop $146.33
Target $161.73
RSI: 50 | Current: $154.03

Market Sentiment

50
Neutral

Stock Metrics

Daily Vol
0%
VIX Est
20
Weekly
0%

Insider Trading

Insider Role Date Type Value
Marshall Fiona Officer Feb 12 '26 Proposed Sale 4960277.0
Bulto Carulla Victor Officer Feb 09 '26 Proposed Sale 1171576.0
Marshall Fiona Officer May 23 '25 Proposed Sale 1690181.0
Kowalski Robert William Officer Apr 30 '25 Proposed Sale 137297.0

Source: FinViz — Data may be delayed

NVS News Intelligence (2 articles)

AI-curated news influencing NVS price, sentiment, and trend

Explore All NVS News with AI Analysis
Stocks
1 day, 22 hours ago

Neurocrine wants to develop new obesity drugs. It’s making an acquisition to accelerate that move.

Soleno Therapeutics stock is soaring on Monday in premarket after a report that Neurocrine is nearing a deal to buy …

Impact on NVS: Soleno Therapeutics' stock is soaring in premarket trading, with potential for a …
Neurocrine's potential acquisition of Soleno Therapeutics is driving a surge in Soleno's stock price, with … High (80%)
View full analysis →
MarketWatch 80% confidence
Economy
3 weeks ago

SNB Is About to Reveal Its Resolve on Franc Strength

The Swiss National Bank’s determination to cap gains in the franc will draw the spotlight in a decision that is …

Impact on NVS: A strong stance by the SNB to cap franc gains may lead …
The Swiss National Bank (SNB) is set to announce its decision on capping gains in … High (70%)
View full analysis →
Bloomberg 70% confidence
🤖

AI Analysis

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
0%
AI Model Multi-Provider AI Analysis
Open article